The aforementioned findings are quite significant in view of the fact that protein kinases represent a group of molecular targets characterized by a cancer specific potential, allowing the development of new generation chemotherapeutic agents acting as kinase inhibitors.
← all excerpts
ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
1
—
—